Extending inflamed-class signature to predict immune checkpoint inhibitor-based combination therapy in hepatocellular carcinoma

Wenhua You(Nanjing Medical University), Yun Chen(Southeast University), Yedi Huang(Jiangsu Cancer Hospital), Yuhan Zhang(First Affiliated Hospital of Henan University), Ling Li(Dalian Medical University), Jinying Lu(Jiangsu Cancer Hospital), Mengya Zhao(Jiangsu Cancer Hospital), Chupeng Hu(Jiangsu Cancer Hospital)
Gut
September 11, 2024
10.1136/gutjnl-2024-333375
Cited by 5

Related Papers

Gut microbiota–derived short‐chain fatty acids regulate group 3 innate lymphoid cells in HCC
|Hepatology|2022|181
Gastric Microbiome Alterations Are Associated with Decreased CD8+ Tissue-Resident Memory T Cells in the Tumor Microenvironment of Gastric Cancer
|Cancer Immunology Research|2022|120
Important role of the SDF-1/CXCR4 axis in the homing of systemically transplanted human amnion-derived mesenchymal stem cells (hAD-MSCs) to ovaries in rats with chemotherapy-induced premature ovarian insufficiency (POI)
|Stem Cell Research & Therapy|2022|96
Tumor-associated macrophages promote PD-L1 expression in tumor cells by regulating PKM2 nuclear translocation in pancreatic ductal adenocarcinoma
|Oncogene|2021|91
Tertiary Lymphoid Structure-Associated B Cells Enhance CXCL13+CD103+CD8+ Tissue-Resident Memory T-Cell Response to Programmed Cell Death Protein 1 Blockade in Cancer Immunotherapy
|Gastroenterology|2023|79